Charles River Laboratories International (CRL) Other Non Operating Income (2009 - 2026)

Charles River Laboratories International's Other Non Operating Income history runs 17 years deep, the most recent figure standing at $12.1 million for Q4 2025.

• In Q4 2025, Other Non Operating Income rose 153.29% year-over-year to $12.1 million; the TTM figure through Dec 2025 stood at -$22.6 million (down 36.66% YoY), while the FY2025 annual figure was -$22.6 million, down 36.66% from the prior year.
• Other Non Operating Income for Q4 2025 stood at $12.1 million, up from -$22.6 million in the prior quarter.
• The five-year high for Other Non Operating Income was $115.5 million in Q4 2022, with the low at -$39.8 million in Q2 2022.
• The 5-year median for Other Non Operating Income is -$3.0 million (2023), against an average of $2.6 million.
• The sharpest annual moves came in 2022 and 2025: Other Non Operating Income soared 5476.59% in 2022, then slumped 972.61% in 2025.
• Charles River Laboratories International's Other Non Operating Income stood at $2.1 million in 2021, then jumped by 5476.59% to $115.5 million in 2022, then decreased by 6.76% to $107.7 million in 2023, then sank by 121.07% to -$22.7 million in 2024, then surged by 153.29% to $12.1 million in 2025.
• Business Quant data shows CRL's Other Non Operating Income at $12.1 million in Q4 2025, -$22.6 million in Q3 2025, and $154000.0 in Q2 2025.